There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Palvella Therapeutics (PVLA – Research Report) ...
H.C. Wainwright raised the firm’s price target on Corcept Therapeutics (CORT) to $115 from $80 and keeps a Buy rating on the shares. The firm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback